🎯 check Pemigatinib (INCB054828) product page
Pemigatinib is a selective, reversible FGFR inhibitor. It affects FGFR signaling by inhibiting kinases, halting tumor growth.
Pemigatinib (INCB054828): Mechanism of Action
Pemigatinib (INCB054828) MOA：Targeting FGFR2/FGFR Signaling Pathway for Cholangiocarcinoma
Jump to
- Pemigatinib (INCB054828) Clinical Trials
- Pemigatinib (INCB054828) Working Concentration | Cell Culture | Treatment
- Pemigatinib (INCB054828) Solubility in DMSO
- Pemigatinib (INCB054828) Stock Solution
- Pemigatinib (INCB054828) Storage
- Pemigatinib (INCB054828) Stability
- Pemigatinib (INCB054828) Combination Database
- Pemigatinib (INCB054828) Molecular Weight
- Pemigatinib (INCB054828) SMILES
- Pemigatinib (INCB054828) CAS Number
- Pemigatinib (INCB054828) Chemical Structure (2D and 3D)
- Pemigatinib (INCB054828) IC50 for Cell-based and Cell-free Assays
- Pemigatinib (INCB054828) Cayman (33260)? Try a better option.
- Pemigatinib (INCB054828) MedChemExpress (HY-109099)? Try a better option.
- Pemigatinib (INCB054828) Sigma (AMBH95E07CE5)? Try a better option.
- Pemigatinib (INCB054828) APExBIO (A4690)? Try a better option.
- Pemigatinib (INCB054828) SDS｜MSDS